Genopathy
Gene-Disorder Association · Article
Gene
BRAF
B-Raf Proto-Oncogene, Serine/Threonine Kinase
Disorder
Melanoma
Manually curatedApproved treatment annotated
Association Review

In brief

The association between BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) and Melanoma is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.

Sources 2
Clinical variants 4
Symptoms 2
Compounds 13
Trials 958of 9,021 via BRAF compounds
Publications 126
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
BRAF

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Melanoma

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

4 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Interventions

Therapeutics

13 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
08
Human studies

Clinical trials

9,021 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
09
Literature

Reading

126 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
10
Provenance

References & sources

21 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access